Park National Corporation (PRK)
Official siteFINANCIAL SERVICES • BANKS - REGIONAL • AMEX
Market Cap: $3.19B
Last updated: Nov 17, 2026 at 11:06 AM ET
Park National Corporation (PRK) Stock Forecast
Analysts expect Park National (PRK) to earn $13.01 per share in the fiscal year ending Dec 31, 2026, on revenue of $691.33M. Of 5 analysts, 0 rate the stock Buy or Strong Buy, 5 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 3 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 5 ratings average 3.00, inside the Hold band from 2.5 up to 3.5. All 5 rate it Hold.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 0 | 0.0% |
| Hold | 5 | 100.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 5
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 1.0% and revenue estimates rise 3.3%.
- Fiscal year ending Dec 31, 2026
- $13.01
- EPS consensus, revenue $691.33M
- Fiscal year ending Dec 31, 2027
- $13.14
- EPS consensus, revenue $714.26M
- Next report
- Jan 25, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $13.01 | $12.80 to $13.21 | 4 | $691.33M | $687.50M to $695.70M | 4 |
| Dec 31, 2027 | $13.14 | $12.88 to $13.40 | 5 | $714.26M | $704.00M to $722.40M | 4 |
Quarterly Estimates
The EPS consensus falls from $3.27 for the quarter ending Dec 31, 2026 to $3.22 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $3.27 | $3.04 to $3.63 | 5 | $179.41M | $172.10M to $190.37M | 4 |
| Mar 31, 2027 | $3.22 | $3.14 to $3.32 | 5 | $175.50M | $174.00M to $177.10M | 4 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 4 upward and 8 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 3 |
| Fiscal year ending Dec 31, 2027 | 2 | 2 |
| Quarter ending Mar 31, 2027 | 1 | 3 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 0.2% from $12.99.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $13.01 | $13.00 | $13.00 | $12.99 | $12.99 | +0.2% |
| Fiscal year ending Dec 31, 2027 | $13.14 | $13.30 | $13.30 | $13.23 | $13.23 | -0.7% |
| Quarter ending Mar 31, 2027 | $3.22 | $3.29 | $3.29 | $3.27 | $3.27 | -1.4% |
Frequently Asked Questions About PRK
What is the PRK stock forecast?
Consensus analyst estimates put Park National's EPS at $13.01 for the fiscal year ending Dec 31, 2026, on revenue of $691.33M. The consensus rating from 5 analysts is Hold.
How do analysts rate PRK stock?
Of 5 analysts covering Park National, 0 rate it Strong Buy, 0 Buy, 5 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from PRK next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $13.01, with estimates from $12.80 to $13.21 from 4 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $13.14, with estimates from $12.88 to $13.40 from 5 analysts.
What revenue do analysts expect from Park National next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $691.33M, with estimates from $687.50M to $695.70M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $714.26M, with estimates from $704.00M to $722.40M.
How many analysts cover PRK?
5 analysts rate Park National stock, and 4 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
PRK pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors